Article Versions Notes

Marczyk M, Patwardhan GA, Zhao J, Qu R, Li X, Wali VB, Gupta AK, Pillai MM, Kluger Y, Yan Q, et al. Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells. Cancers. 2020; 12(9):2551. https://doi.org/10.3390/cancers12092551

Marczyk, Michal, Gauri A. Patwardhan, Jun Zhao, Rihao Qu, Xiaotong Li, Vikram B. Wali, Abhishek K. Gupta, Manoj M. Pillai, Yuval Kluger, Qin Yan, and et al. 2020. "Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells" Cancers 12, no. 9: 2551. https://doi.org/10.3390/cancers12092551

Marczyk, M., Patwardhan, G. A., Zhao, J., Qu, R., Li, X., Wali, V. B., Gupta, A. K., Pillai, M. M., Kluger, Y., Yan, Q., Hatzis, C., Pusztai, L., & Gunasekharan, V. (2020). Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells. Cancers, 12(9), 2551. https://doi.org/10.3390/cancers12092551